☆ 4.7 Article

Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

添加到收藏夹

Letter Infectious Diseases

Genotypic and phenotypic analyses of aac(3) aminoglycoside-resistance gene diversity point to three distinct phenotypes of contemporary clinical relevance

Michel Plattner et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)

添加到收藏夹

Article Infectious Diseases

Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia

Vincent Aranzana-Climent et al.

Summary: This study characterized the preclinical pharmacokinetics (PK) and pharmacodynamics of the drug candidate apramycin in fighting carbapenem-resistant gram-negative pathogens. A mathematical model was developed to predict human efficacy based on in vitro and in vivo data. Apramycin showed good lung penetration and the mathematical model integrated lung PK to drive mouse PK and pharmacodynamics. Apramycin was demonstrated as a candidate for treatment of carbapenem-resistant gram-negative pneumonia.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Infectious Diseases

Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose

Chenyan Zhao et al.

Summary: The aim of this study was to conduct a population pharmacokinetic analysis of apramycin and predict an efficacious dose based on data from the Phase I trial. The results showed that an anticipated efficacious dose of 30 mg/kg daily could be used for further Phase II clinical trials.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice

Katja Becker et al.

Summary: The study demonstrates the efficacy of EBL-1003 in treating CRAB lung infections, showing broad in vitro coverage, rapid killing, and high probability of target attainment.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin

Tomas Sou et al.

Summary: This study investigated the potential of using PK/PD modeling to predict the efficacious dose of aprmycin in humans and analyzed susceptibility and resistance development in different strains. The results indicate that the mechanistic PK/PD modeling approach is suitable for HED prediction and has the potential to improve predictive capacity.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Microbiology

Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance

Christopher A. Darlow et al.

Summary: Antimicrobial resistance in neonatal sepsis is a global issue, with high mortality rates in low- and middle-income countries. A combination therapy of fosfomycin and amikacin shows enhanced bactericidal activity and synergy against resistant strains. Monte Carlo simulations support the efficacy of this combination regimen for the treatment of neonatal sepsis.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Medicine, General & Internal

Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis

Katja Becker et al.

Summary: EBL-1003 shows broad-spectrum activity and rapid CFU reduction against a variety of Gram-negative uropathogens, including aminoglycoside-resistant clinical isolates. In mouse infection models, EBL-1003 exhibits potent efficacy and lower nephrotoxicity compared to gentamicin.

EBIOMEDICINE (2021)

添加到收藏夹

Article Microbiology

Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries

Kirsty Sands et al.

Summary: The BARNARDS study analyzed bacterial isolates from neonates with sepsis in LMICs, showing antimicrobial-resistant Klebsiella, Escherichia coli, and Enterobacter as main species. Antimicrobial resistance is rising in neonatal sepsis, with poorly understood mechanisms that limit treatment options in LMICs.

NATURE MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study

Kristina E. Rudd et al.

LANCET (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Geneaac(3)-IV

Michel Plattner et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Medicine, General & Internal

Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data

Paul Turner et al.

BMC MEDICINE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use

Masaaki Ishikawa et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Infectious Diseases

In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii

Mario Juhas et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

添加到收藏夹

Review Pediatrics

Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children

Aline Fuchs et al.

PAEDIATRICS AND INTERNATIONAL CHILD HEALTH (2018)

添加到收藏夹

Article Public, Environmental & Occupational Health

Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional study

Lancet Global Health (2017)

添加到收藏夹

Article Infectious Diseases

In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

Anthony D. Kang et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin

Tanja Matt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.